Single or Double Induction with 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: the Randomized DaunoDouble Trial by the Study Alliance Leukemia. Christoph Roellig , Bjoern Steffen , Christoph Schliemann , Jan-Henrik Mikesch , Nael Alakel , Regina Herbst , Mathias Haenel , Richard Noppeney , Maher Hanoun , Martin Kaufmann , Barbora Weinbergerova , Kerstin Schaefer-Eckart , Tim Sauer , Andreas Neubauer , Andreas Burchert , Claudia D. Baldus , Jolana Mertova , Edgar Jost , Dirk Niemann , Jan Novak , Stefan W. Krause , Sebastian Scholl , Andreas Hochhaus , Gerhard Held , Tomas Szotkowski , Andreas Rank , Christoph Schmid , Lars Fransecky , Sabine Kayser , Markus Schaich , Michael Kramer , Frank Fiebig , Annett Haake , Johannes Schetelig , Jan Moritz Middeke , Friedrich Stoelzel , Uwe Platzbecker , Christian Thiede , Carsten Mueller-Tidow , Wolfgang E. Berdel , Gerhard Ehninger , Jiri Mayer , Hubert Serve , Martin Bornhaeuser JOURNAL OF CLINICAL ONCOLOGY（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
